S&P 500   4,609.24 (+1.56%)
DOW   35,330.62 (+2.17%)
QQQ   387.00 (+1.01%)
AAPL   166.30 (+2.76%)
MSFT   324.81 (+0.56%)
FB   317.35 (+3.43%)
GOOGL   2,866.63 (+0.94%)
AMZN   3,463.59 (+2.18%)
TSLA   1,012.00 (-0.29%)
NVDA   298.38 (-2.79%)
BABA   122.21 (+9.16%)
NIO   32.15 (+0.00%)
CGC   10.21 (+2.20%)
AMD   138.82 (-3.60%)
GE   96.70 (+4.24%)
MU   82.66 (+1.27%)
T   23.49 (+0.13%)
F   19.41 (+1.41%)
DIS   150.32 (+2.80%)
PFE   52.10 (-4.00%)
AMC   29.61 (+2.07%)
ACB   5.99 (+2.92%)
BA   205.56 (+3.56%)
S&P 500   4,609.24 (+1.56%)
DOW   35,330.62 (+2.17%)
QQQ   387.00 (+1.01%)
AAPL   166.30 (+2.76%)
MSFT   324.81 (+0.56%)
FB   317.35 (+3.43%)
GOOGL   2,866.63 (+0.94%)
AMZN   3,463.59 (+2.18%)
TSLA   1,012.00 (-0.29%)
NVDA   298.38 (-2.79%)
BABA   122.21 (+9.16%)
NIO   32.15 (+0.00%)
CGC   10.21 (+2.20%)
AMD   138.82 (-3.60%)
GE   96.70 (+4.24%)
MU   82.66 (+1.27%)
T   23.49 (+0.13%)
F   19.41 (+1.41%)
DIS   150.32 (+2.80%)
PFE   52.10 (-4.00%)
AMC   29.61 (+2.07%)
ACB   5.99 (+2.92%)
BA   205.56 (+3.56%)
S&P 500   4,609.24 (+1.56%)
DOW   35,330.62 (+2.17%)
QQQ   387.00 (+1.01%)
AAPL   166.30 (+2.76%)
MSFT   324.81 (+0.56%)
FB   317.35 (+3.43%)
GOOGL   2,866.63 (+0.94%)
AMZN   3,463.59 (+2.18%)
TSLA   1,012.00 (-0.29%)
NVDA   298.38 (-2.79%)
BABA   122.21 (+9.16%)
NIO   32.15 (+0.00%)
CGC   10.21 (+2.20%)
AMD   138.82 (-3.60%)
GE   96.70 (+4.24%)
MU   82.66 (+1.27%)
T   23.49 (+0.13%)
F   19.41 (+1.41%)
DIS   150.32 (+2.80%)
PFE   52.10 (-4.00%)
AMC   29.61 (+2.07%)
ACB   5.99 (+2.92%)
BA   205.56 (+3.56%)
S&P 500   4,609.24 (+1.56%)
DOW   35,330.62 (+2.17%)
QQQ   387.00 (+1.01%)
AAPL   166.30 (+2.76%)
MSFT   324.81 (+0.56%)
FB   317.35 (+3.43%)
GOOGL   2,866.63 (+0.94%)
AMZN   3,463.59 (+2.18%)
TSLA   1,012.00 (-0.29%)
NVDA   298.38 (-2.79%)
BABA   122.21 (+9.16%)
NIO   32.15 (+0.00%)
CGC   10.21 (+2.20%)
AMD   138.82 (-3.60%)
GE   96.70 (+4.24%)
MU   82.66 (+1.27%)
T   23.49 (+0.13%)
F   19.41 (+1.41%)
DIS   150.32 (+2.80%)
PFE   52.10 (-4.00%)
AMC   29.61 (+2.07%)
ACB   5.99 (+2.92%)
BA   205.56 (+3.56%)
NYSE:HUM

Humana Stock Forecast, Price & News

$435.77
+14.07 (+3.34%)
(As of 12/6/2021 01:27 PM ET)
Add
Compare
Today's Range
$424.29
$435.79
50-Day Range
$384.96
$467.60
52-Week Range
$370.22
$475.44
Volume
27,534 shs
Average Volume
875,718 shs
Market Capitalization
$56.01 billion
P/E Ratio
21.04
Dividend Yield
0.66%
Beta
0.92
30 days | 90 days | 365 days | Advanced Chart
Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.


Humana logo

About Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance benefits. The Healthcare Services segment offer services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics services to other Humana businesses, as well as external health plan members, external health plans, and other employers. The company was founded by David A. Jones, Sr. and Wendell Cherry in 1961 and is headquartered in Louisville, KY.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
Sector
Medical
CUSIP
44485910
Employees
48,700
Year Founded
1961

Sales & Book Value

Annual Sales
$77.16 billion
Cash Flow
$24.30 per share
Book Value
$126.67 per share

Profitability

Net Income
$3.37 billion
Pretax Margin
3.65%

Debt

Price-To-Earnings

Miscellaneous

Free Float
128,020,000
Market Cap
$56.01 billion
Optionable
Optionable

Company Calendar

Ex-Dividend
9/29/2021
Dividend Payable
10/29/2021
Last Earnings
11/03/2021
Today
12/06/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/02/2022

Social Links


MarketRank

Overall MarketRank

3.10 out of 5 stars

Medical Sector

15th out of 1,390 stocks

Hospital & Medical Service Plans Industry

3rd out of 13 stocks

Analyst Opinion: 3.4Community Rank: 4.4Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -












Humana (NYSE:HUM) Frequently Asked Questions

Is Humana a buy right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Humana stock.
View analyst ratings for Humana
or view top-rated stocks.

How has Humana's stock been impacted by COVID-19?

Humana's stock was trading at $328.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HUM shares have increased by 32.8% and is now trading at $435.77.
View which stocks have been most impacted by COVID-19
.

When is Humana's next earnings date?

Humana is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Humana
.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) issued its quarterly earnings data on Wednesday, November, 3rd. The insurance provider reported $4.83 earnings per share for the quarter, topping analysts' consensus estimates of $4.61 by $0.22. The insurance provider earned $20.70 billion during the quarter, compared to analyst estimates of $20.91 billion. Humana had a trailing twelve-month return on equity of 14.95% and a net margin of 3.30%. Humana's revenue was up 3.1% on a year-over-year basis. During the same period in the prior year, the firm earned $3.08 EPS.
View Humana's earnings history
.

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Thursday, October 28th. Stockholders of record on Friday, December 31st will be paid a dividend of $0.70 per share on Friday, January 28th. This represents a $2.80 annualized dividend and a yield of 0.64%. The ex-dividend date of this dividend is Thursday, December 30th.
View Humana's dividend history
.

Is Humana a good dividend stock?

Humana pays an annual dividend of $2.80 per share and currently has a dividend yield of 0.66%. Humana has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Humana is 13.52%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Humana will have a dividend payout ratio of 11.67% next year. This indicates that Humana will be able to sustain or increase its dividend.
View Humana's dividend history.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY 2021 earnings guidance on Wednesday, December, 1st. The company provided earnings per share guidance of $20.500-$20.500 for the period, compared to the Thomson Reuters consensus estimate of $20.530. The company issued revenue guidance of -.

What price target have analysts set for HUM?

16 brokers have issued 12 month price objectives for Humana's shares. Their forecasts range from $450.00 to $559.00. On average, they expect Humana's share price to reach $503.98 in the next year. This suggests a possible upside of 15.7% from the stock's current price.
View analysts' price targets for Humana
or view top-rated stocks among Wall Street analysts.

Who are Humana's key executives?

Humana's management team includes the following people:
  • Bruce Dale Broussard, President, Chief Executive Officer & Director
  • Susan M. Diamond, Chief Financial Officer
  • Brian P. LeClaire, Chief Information Officer & Senior Vice President
  • Sam Deshpande, SVP, Chief Risk & Technology Officer
  • Alefiyah Mesiwala, Chief Medical Officer

What is Bruce D. Broussard's approval rating as Humana's CEO?

1,597 employees have rated Humana CEO Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among Humana's employees.

Who are some of Humana's key competitors?

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), salesforce.com (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Who are Humana's major shareholders?

Humana's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.22%), Wellington Management Group LLP (5.03%), Viking Global Investors LP (2.34%), Capital Research Global Investors (2.02%), Capital World Investors (1.97%) and Geode Capital Management LLC (1.52%). Company insiders that own Humana stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, Elizabeth D Bierbower, Jorge S Mesquita, Timothy Alan Wheatley and Timothy S Huval.
View institutional ownership trends for Humana
.

Which major investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including GQG Partners LLC, Capital World Investors, BlackRock Inc., Panagora Asset Management Inc., Thrivent Financial for Lutherans, Bank of New York Mellon Corp, American Century Companies Inc., and Invesco Ltd.. Company insiders that have sold Humana company stock in the last year include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, Timothy Alan Wheatley, and Timothy S Huval.
View insider buying and selling activity for Humana
or view top insider-selling stocks.

Which major investors are buying Humana stock?

HUM stock was purchased by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Wellington Management Group LLP, CI Investments Inc., Ceredex Value Advisors LLC, Natixis, Pura Vida Investments LLC, Citadel Advisors LLC, and Morgan Stanley.
View insider buying and selling activity for Humana
or or view top insider-buying stocks.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $435.77.

How much money does Humana make?

Humana has a market capitalization of $56.01 billion and generates $77.16 billion in revenue each year. The insurance provider earns $3.37 billion in net income (profit) each year or $20.71 on an earnings per share basis.

How many employees does Humana have?

Humana employs 48,700 workers across the globe.

Does Humana have any subsidiaries?

The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II.

When was Humana founded?

Humana was founded in 1961.

What is Humana's official website?

The official website for Humana is www.humana.com.

Where are Humana's headquarters?

Humana is headquartered at 500 West Main Street, LOUISVILLE KY, 40202.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at (502) 580-1000, via email at [email protected], or via fax at 502-580-3639.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.